产品中心

Relenza, the new flu treatment controversially excluded from the NHS because a panel decided it was not cost-effective, can cause breathing difficulties in patients with asthma. Glaxo Wellcome, which makes the drug, warned doctors of the danger last week. The company says the number of people who have suffered breathing difficulties after taking the drug is tiny, and that the warning is simply a precaution. But the news is unfortunate,